Search
Standard BioTools Inc
LABAdd to Watchlist
0.913USD
+0.046+5.32%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
356.16MMarket Cap
4.57P/E TTM
More Details of Standard BioTools Inc Company
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Standard BioTools Inc Info
Ticker SymbolLAB
Company nameStandard BioTools Inc
IPO dateFeb 10, 2011
CEOEgholm (Michael)
Number of employees818
Security typeOrdinary Share
Fiscal year-endFeb 10
Address2 Tower Place
CitySOUTH SAN FRANCISCO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94080
Phone16502666000
Websitehttps://www.standardbio.com/
Ticker SymbolLAB
IPO dateFeb 10, 2011
CEOEgholm (Michael)
Company Executives of Standard BioTools Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
222.69K
+44.51%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
222.69K
+44.51%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Standard BioTools Inc?
The top five shareholders of Standard BioTools Inc are: Mr. Sean Mackay
How many institutions hold shares of Standard BioTools Inc (LAB)?
As of 2026Q1, 342 institutions hold shares of Standard BioTools Inc, with a combined market value of approximately 317.36M, accounting for 81.30% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 773508.00.
What is the biggest source of revenue for Standard BioTools Inc?
In 2026Q1, the Consumables business generated the highest revenue for Standard BioTools Inc, amounting to 36.25M and accounting for 42.48% of total revenue.